Ichor Therapeutics, a New York biotechnology company founded by original SRF Education leader Kelsey Moody, has announced $1.35m in new funding. The investments will be used to expand pre-clinical facilities and support Ichor's ongoing work on age-related disease.

The SENS Research Foundation-funded team at Rice University has just published an open access paper detailing a fast, simple method for generating the age-related pigment lipofuscin in cells and screening the effectiveness of drugs for its removal.

Our CSO Dr. Aubrey de Grey, and Buck Institute for Research on Aging CEO Brian Kennedy, successfully opposed the motion that "Lifespans Are Long Enough" in debate at the Kaufman Center on February 3rd. A full video of the debate is now available.

SRF is looking to hire a new Information Technology technician who specializes in network engineering and systems administration.  The position calls for high-level support and technical expertise in networking technology and related fields.

Check out all the latest news from SENS Research Foundation in our February newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!

The SRF Summer Scholars Program offers undergraduate students the opportunity to conduct research to combat the diseases of aging. What kind of impact can the program have on your education and career? We invited a few alumni back to tell us in their own words.

An SRF-supported team at the Buck Institute has identified a distinct form of mitochondrially-driven cellular senescence. The phenomenon may be a factor in any disease with a mitochondrial component, including many neurodegenerative conditions.

We're pleased to confirm that SENS Research Foundation now has an account with Scottrade enabling us to receive donations of stock. Donating appreciated securities can reduce your capital gains and income tax liabilities.

SENS Research Foundation is delighted to have received donations totalling $27,317 on #GivingTuesday 2015 - more than double the amount given last year. Thanks to our generous matching grants, we were able to raise an amazing total of $74,634!

Members of the Methuselah Foundation's 300 Initiative make a 25-year pledge to donate at least $1,000 annually towards the fight against aging-related disease. A monument honoring these visionaries has just been unveiled - but there's still room to add your name!

Shopping for gifts on Amazon this holiday season? When you use our Amazon Smile link, Amazon automatically donates part of your payment to SRF - and it won't cost you an extra cent!

Our second keynote video from RB2015 is "Science and Technology for Diplomacy", given by Frances Colón, Acting Science & Technology Adviser to the U.S. Secretary of State.

An SRF-funded study by Yale University Professor David Spiegel has been published in world-leading journal Science. The discoveries announced will accelerate future research in the fields of diabetes and age-related tissue cross-linking.

SENS Research Foundation extends our warmest thanks to lifespan.io and the 384 donors who together contributed a total of $46,128 to fund the expansion of our work on mitochondrial rejuvenation.

Video is now available for the first keynote talk of RB2015, "Transforming the Discovery of New Medicines" by Oxford University Professor of Translational Medicine, Chas Bountra.

SENS Research Foundation has been recognised as a Top-Rated Nonprofit by GreatNonprofits.org - the only people's choice award in the nonprofit sector. As a result we'll be listed in their #GivingTuesday guide. Visit their site to read reviews of our work, and add your own!

An open access paper by SENS Research Foundation-funded researcher Brian O'Nuallain has just been published in PLOS One. It identifies an inherent amyloid-binding property of human antibodies which may explain the limited success of prior immunotherapy trials.

Ichor Therapeutics, a New York biotechnology company founded by original SRF Education leader Kelsey Moody, has announced $1.35m in new funding. The investments will be used to expand pre-clinical facilities and support Ichor's ongoing work on age-related disease.

The SENS Research Foundation-funded team at Rice University has just published an open access paper detailing a fast, simple method for generating the age-related pigment lipofuscin in cells and screening the effectiveness of drugs for its removal.

Our CSO Dr. Aubrey de Grey, and Buck Institute for Research on Aging CEO Brian Kennedy, successfully opposed the motion that "Lifespans Are Long Enough" in debate at the Kaufman Center on February 3rd. A full video of the debate is now available.

SRF is looking to hire a new Information Technology technician who specializes in network engineering and systems administration.  The position calls for high-level support and technical expertise in networking technology and related fields.

Check out all the latest news from SENS Research Foundation in our February newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!

The SRF Summer Scholars Program offers undergraduate students the opportunity to conduct research to combat the diseases of aging. What kind of impact can the program have on your education and career? We invited a few alumni back to tell us in their own words.

An SRF-supported team at the Buck Institute has identified a distinct form of mitochondrially-driven cellular senescence. The phenomenon may be a factor in any disease with a mitochondrial component, including many neurodegenerative conditions.

We're pleased to confirm that SENS Research Foundation now has an account with Scottrade enabling us to receive donations of stock. Donating appreciated securities can reduce your capital gains and income tax liabilities.

SENS Research Foundation is delighted to have received donations totalling $27,317 on #GivingTuesday 2015 - more than double the amount given last year. Thanks to our generous matching grants, we were able to raise an amazing total of $74,634!

Members of the Methuselah Foundation's 300 Initiative make a 25-year pledge to donate at least $1,000 annually towards the fight against aging-related disease. A monument honoring these visionaries has just been unveiled - but there's still room to add your name!

Shopping for gifts on Amazon this holiday season? When you use our Amazon Smile link, Amazon automatically donates part of your payment to SRF - and it won't cost you an extra cent!

Our second keynote video from RB2015 is "Science and Technology for Diplomacy", given by Frances Colón, Acting Science & Technology Adviser to the U.S. Secretary of State.

An SRF-funded study by Yale University Professor David Spiegel has been published in world-leading journal Science. The discoveries announced will accelerate future research in the fields of diabetes and age-related tissue cross-linking.

SENS Research Foundation extends our warmest thanks to lifespan.io and the 384 donors who together contributed a total of $46,128 to fund the expansion of our work on mitochondrial rejuvenation.

Video is now available for the first keynote talk of RB2015, "Transforming the Discovery of New Medicines" by Oxford University Professor of Translational Medicine, Chas Bountra.

SENS Research Foundation has been recognised as a Top-Rated Nonprofit by GreatNonprofits.org - the only people's choice award in the nonprofit sector. As a result we'll be listed in their #GivingTuesday guide. Visit their site to read reviews of our work, and add your own!

An open access paper by SENS Research Foundation-funded researcher Brian O'Nuallain has just been published in PLOS One. It identifies an inherent amyloid-binding property of human antibodies which may explain the limited success of prior immunotherapy trials.

Ichor Therapeutics, a New York biotechnology company founded by original SRF Education leader Kelsey Moody, has announced $1.35m in new funding. The investments will be used to expand pre-clinical facilities and support Ichor's ongoing work on age-related disease.

The SENS Research Foundation-funded team at Rice University has just published an open access paper detailing a fast, simple method for generating the age-related pigment lipofuscin in cells and screening the effectiveness of drugs for its removal.

Our CSO Dr. Aubrey de Grey, and Buck Institute for Research on Aging CEO Brian Kennedy, successfully opposed the motion that "Lifespans Are Long Enough" in debate at the Kaufman Center on February 3rd. A full video of the debate is now available.

SRF is looking to hire a new Information Technology technician who specializes in network engineering and systems administration.  The position calls for high-level support and technical expertise in networking technology and related fields.

Check out all the latest news from SENS Research Foundation in our February newsletter. You might also like to check out the archive of past messages, or subscribe to our mailing list to make sure you don't miss out on future updates!

The SRF Summer Scholars Program offers undergraduate students the opportunity to conduct research to combat the diseases of aging. What kind of impact can the program have on your education and career? We invited a few alumni back to tell us in their own words.

An SRF-supported team at the Buck Institute has identified a distinct form of mitochondrially-driven cellular senescence. The phenomenon may be a factor in any disease with a mitochondrial component, including many neurodegenerative conditions.

We're pleased to confirm that SENS Research Foundation now has an account with Scottrade enabling us to receive donations of stock. Donating appreciated securities can reduce your capital gains and income tax liabilities.

SENS Research Foundation is delighted to have received donations totalling $27,317 on #GivingTuesday 2015 - more than double the amount given last year. Thanks to our generous matching grants, we were able to raise an amazing total of $74,634!

Members of the Methuselah Foundation's 300 Initiative make a 25-year pledge to donate at least $1,000 annually towards the fight against aging-related disease. A monument honoring these visionaries has just been unveiled - but there's still room to add your name!

Shopping for gifts on Amazon this holiday season? When you use our Amazon Smile link, Amazon automatically donates part of your payment to SRF - and it won't cost you an extra cent!

Our second keynote video from RB2015 is "Science and Technology for Diplomacy", given by Frances Colón, Acting Science & Technology Adviser to the U.S. Secretary of State.

An SRF-funded study by Yale University Professor David Spiegel has been published in world-leading journal Science. The discoveries announced will accelerate future research in the fields of diabetes and age-related tissue cross-linking.

SENS Research Foundation extends our warmest thanks to lifespan.io and the 384 donors who together contributed a total of $46,128 to fund the expansion of our work on mitochondrial rejuvenation.

Video is now available for the first keynote talk of RB2015, "Transforming the Discovery of New Medicines" by Oxford University Professor of Translational Medicine, Chas Bountra.

SENS Research Foundation has been recognised as a Top-Rated Nonprofit by GreatNonprofits.org - the only people's choice award in the nonprofit sector. As a result we'll be listed in their #GivingTuesday guide. Visit their site to read reviews of our work, and add your own!

An open access paper by SENS Research Foundation-funded researcher Brian O'Nuallain has just been published in PLOS One. It identifies an inherent amyloid-binding property of human antibodies which may explain the limited success of prior immunotherapy trials.